# REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

> **NCT06788535** · PHASE3 · COMPLETED · sponsor: **Sharmila Dorbala** · enrollment: 204 (actual)

## Conditions studied

- Cardiac Amyloidosis

## Interventions

- **DRUG:** I-124 evuzamitide

## Key facts

- **NCT ID:** NCT06788535
- **Lead sponsor:** Sharmila Dorbala
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-14
- **Primary completion:** 2026-04-08
- **Final completion:** 2026-04-09
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06788535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06788535, "REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06788535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*